Royal Bank of Canada’s iShares Evolved U.S. Innovative Healthcare ETF IEIH Stock Holding History

Royal Bank of Canada’s Portfolio IEIH Stock Details IEIH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-500	Closed	-$15K	–	7113
2020 Q2	$15K	Sell	500 -500	-50%	-$14.4K	﹤0.01%	5705
2020 Q1	$25K	Hold	1,000	–	–	﹤0.01%	5452
2019 Q4	$28K	Hold	1,000	–	–	﹤0.01%	5721
2019 Q3	$24K	Sell	1,000 -1,000	-50%	-$24.8K	﹤0.01%	5428
2019 Q2	$51K	Sell	2,000 -1,000	-33%	-$25K	﹤0.01%	5265
2019 Q1	$78K	Buy	+3,000	New	+$76.5K	﹤0.01%	4922

Other funds holding IEIH

SWM

Strategic Wealth Management Kirkland, Washington $202M AUM 9.35% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

DAS

Dynamic Advisor Solutions Phoenix, Arizona $3.53B AUM 22.61% 1-Year Est. Return

PIMG

Patriot Investment Management Group Knoxville, Tennessee $1.72B AUM 17.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Financial Perspectives Minneapolis, Minnesota $411M AUM 26.27% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Ironwood Financial Tucson, Arizona $639M AUM 19.03% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

Royal Bank of Canada's IEIH Position: Q3 2020 in Review

Royal Bank of Canada sold out of iShares Evolved U.S. Innovative Healthcare ETF (IEIH) in Q3 2020, closing a stake of 500 shares — an estimated $15K sold.

Royal Bank of Canada first reported a position in IEIH in Q1 2019 and held it in 6 quarters. The position peaked at $78K in Q1 2019. 12 funds tracked by Wall St. Rank hold IEIH as of Q3 2020.

Royal Bank of Canada reported no remaining iShares Evolved U.S. Innovative Healthcare ETF position as of Q3 2020 after selling out during the quarter.
Royal Bank of Canada sold 500 iShares Evolved U.S. Innovative Healthcare ETF shares in Q3 2020, an estimated $15K.
Royal Bank of Canada first reported a position in iShares Evolved U.S. Innovative Healthcare ETF in Q1 2019 and held it in 6 quarters.
Royal Bank of Canada's iShares Evolved U.S. Innovative Healthcare ETF position peaked at $78K in Q1 2019.
12 funds tracked by Wall St. Rank held iShares Evolved U.S. Innovative Healthcare ETF as of Q3 2020.

Based on Royal Bank of Canada's 13F filing for Q3 2020, filed 16 Nov 2020.